772 institutions reported holding $10.65B of Halozyme Therapeutics Inc. (HALO) in SEC 13F filings for 2026-06-30. Largest institutional holders: BlackRock, Inc. ($1.05B), VANGUARD GROUP INC ($908.8M), STATE STREET CORP ($424.6M), Invesco Ltd. ($248.7M), MORGAN STANLEY ($225.2M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30